Jazz Pharmaceuticals prices $1.1B exchangeable notes offering due 2032
Tweet Send to a Friend
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has priced a $1.1 billion private offering of 1.875% exchangeable senior notes due 2032, upsized ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
